申请人:Taiho Pharmaceutical Company
公开号:US04243812A1
公开(公告)日:1981-01-06
Novel derivatives of glyoxal-2-oxim represented by the chemical formula ##STR1## wherein R is hydrogen or a lower alkyl or phenyl group, are provided in accordance with the present invention. These derivatives are prepared by reacting the corresponding isoxazole-5-carbaldehyde with nitromethane in the presence of a metal alkoxide, or the corresponding 5-acetylisoxazole with a nitrate. They have anti-inflammatory and/or analgesic activities.
本发明提供了一种以
化学式 ##STR1## 表示的甘氧基-2-
肟的新衍
生物,其中R是氢或较低的烷基或苯基。这些衍
生物是通过在
金属烷氧化物存在下将相应的
异噁唑-5-甲醛与
硝基甲烷反应,或将相应的5-乙酰基
异噁唑与
硝酸盐反应制备的。它们具有抗炎和/或镇痛活性。